Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Sounds | 1 | 2023 | 34 | 0.860 |
Why?
|
| Failure to Thrive | 1 | 2020 | 17 | 0.730 |
Why?
|
| Mucositis | 1 | 2020 | 17 | 0.710 |
Why?
|
| Mycoplasma Infections | 1 | 2020 | 9 | 0.710 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 65 | 0.680 |
Why?
|
| Weight Loss | 1 | 2020 | 233 | 0.640 |
Why?
|
| Oxidative Stress | 2 | 2013 | 458 | 0.390 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2011 | 3 | 0.390 |
Why?
|
| Superoxides | 1 | 2011 | 74 | 0.380 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2010 | 8 | 0.360 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 38 | 0.350 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 200 | 0.340 |
Why?
|
| Myocardium | 1 | 2011 | 573 | 0.310 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 490 | 0.290 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 314 | 0.290 |
Why?
|
| Oxygen | 1 | 2010 | 745 | 0.250 |
Why?
|
| Bronchiolitis | 1 | 2023 | 8 | 0.220 |
Why?
|
| Bronchodilator Agents | 1 | 2023 | 66 | 0.220 |
Why?
|
| Lip Diseases | 1 | 2020 | 1 | 0.180 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2020 | 6 | 0.180 |
Why?
|
| Mouth | 1 | 2020 | 48 | 0.180 |
Why?
|
| Infant | 3 | 2023 | 3187 | 0.170 |
Why?
|
| Arthritis, Infectious | 1 | 2019 | 16 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2019 | 55 | 0.160 |
Why?
|
| Child | 3 | 2023 | 7233 | 0.120 |
Why?
|
| Rats | 2 | 2011 | 4048 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 798 | 0.110 |
Why?
|
| Glutathione | 1 | 2013 | 108 | 0.100 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 68 | 0.100 |
Why?
|
| Humans | 6 | 2023 | 89864 | 0.100 |
Why?
|
| Tachycardia, Ventricular | 1 | 2013 | 124 | 0.100 |
Why?
|
| Ethidium | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 10 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2013 | 172 | 0.100 |
Why?
|
| Diazepam | 1 | 2011 | 27 | 0.100 |
Why?
|
| Salicylates | 1 | 2011 | 25 | 0.100 |
Why?
|
| Fluorescence | 1 | 2011 | 103 | 0.090 |
Why?
|
| Intracellular Membranes | 1 | 2011 | 117 | 0.090 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 158 | 0.090 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2010 | 2 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2010 | 16 | 0.090 |
Why?
|
| Cyclosporine | 1 | 2011 | 238 | 0.090 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2010 | 23 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 137 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8264 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 89 | 0.090 |
Why?
|
| Antioxidants | 1 | 2011 | 226 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 245 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 996 | 0.080 |
Why?
|
| Male | 3 | 2020 | 42614 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2010 | 280 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 418 | 0.080 |
Why?
|
| Albuterol | 1 | 2023 | 35 | 0.050 |
Why?
|
| Animals | 3 | 2013 | 27516 | 0.050 |
Why?
|
| Steroids | 1 | 2023 | 173 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2010 | 3403 | 0.040 |
Why?
|
| Transitional Care | 1 | 2019 | 18 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 416 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 117 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 666 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 9185 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 864 | 0.030 |
Why?
|
| Diamide | 1 | 2013 | 3 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 55 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2013 | 172 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 112 | 0.030 |
Why?
|
| Propensity Score | 1 | 2013 | 149 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 108 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 2886 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3670 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 388 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 3765 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2324 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 5357 | 0.020 |
Why?
|
| Heart | 1 | 2013 | 578 | 0.020 |
Why?
|
| Action Potentials | 1 | 2013 | 600 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 837 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1148 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 9327 | 0.020 |
Why?
|
| Female | 1 | 2019 | 46529 | 0.010 |
Why?
|